Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

202025-10

(1)PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS; AND (2)PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RELATED CORPORATE GOVERNANCE POLICIES
202025-10

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK LOAN AGREEMENT
022025-10

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
292025-09

2025 INTERIM REPORT
282025-08

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
012025-09

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
152025-08

NOTICE OF BOARD MEETING
012025-08

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
022025-07

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
272025-06

List of directors and their roles and functions
272025-06

CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE
272025-06

Nomination Committee – Terms of reference

1 2 3

The Enterprise OA